What does this research mean for the field?

Long-term clinical trial data and real-world experience confirm the safety, efficacy, and rapid onset of sutimlimab as a targeted primary therapy for cold agglutinin disease. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

This review aims to reassess the efficacy and safety of sutimlimab for cold agglutinin disease based on clinical trials and real-world evidence.

July 10, 2026Expert Review of Hematology

Sutimlimab for cold agglutinin disease: an updated perspective from approval to real-world clinical treatment

View Full Paper

Ask AI

Bookmark

Authors

CBCatherine M. BroomeGeorgetown University BFBruno FattizzoUniversity of Milan

Discussion

Member takes

Implication

Review examines sutimlimab's efficacy and safety in cold agglutinin disease, indicating promising real-world applications.

Key Points

This review aims to reassess the efficacy and safety of sutimlimab for cold agglutinin disease based on clinical trials and real-world evidence.
Review of clinical trial data from CARDINAL and CADENZA
Analysis of post-marketing real-world experience (RWE)
Literature searches on cold agglutinin disease and sutimlimab in relevant databases.
Sutimlimab shows rapid onset of activity in halting hemolysis, essential in acute cases.
Long-term RWE supports the continued safety and efficacy of sutimlimab in managing CAD.
Targeting the complement pathway offers a novel approach, reducing reliance on traditional immunosuppressive therapies.

Cite This Study

Broome et al. (2026) studied this question.

synapsesocial.com/papers/6a508e5b6eeac72a437a1462 https://doi.org/10.1080/17474086.2026.2699806

View Full Paper

Ask AI

Bookmark

Sutimlimab for cold agglutinin disease: an updated perspective from approval to real-world clinical treatment

Discussion

Member takes

Implication

Key Points

Cite This Study

Sutimlimab for cold agglutinin disease: an updated perspective from approval to real-world clinical treatment

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider